THC Biomed Intl Ltd.

CNSX:THC Rapporto sulle azioni

Cap. di mercato: CA$3.3m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

THC Biomed Intl Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

John Miller

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO9.1yrs
Proprietà del CEO19.1%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione8.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?

Oct 11
Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?

Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?

Jun 26
Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?

Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?

Mar 13
Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?

Is THC Biomed Intl (CSE:THC) Using Too Much Debt?

Aug 30
Is THC Biomed Intl (CSE:THC) Using Too Much Debt?

We Think THC Biomed Intl (CSE:THC) Has A Fair Chunk Of Debt

Mar 25
We Think THC Biomed Intl (CSE:THC) Has A Fair Chunk Of Debt

Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?

Dec 02
Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?

Is THC Biomed Intl (CSE:THC) Using Too Much Debt?

Jun 01
Is THC Biomed Intl (CSE:THC) Using Too Much Debt?

Analysts Expect Breakeven For THC Biomed Intl Ltd. (CSE:THC) Before Long

Apr 06
Analysts Expect Breakeven For THC Biomed Intl Ltd. (CSE:THC) Before Long

Would THC Biomed Intl (CSE:THC) Be Better Off With Less Debt?

Jan 08
Would THC Biomed Intl (CSE:THC) Be Better Off With Less Debt?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di John Miller rispetto agli utili di THC Biomed Intl?
DataCompenso totaleStipendioGuadagni aziendali
Apr 30 2023n/an/a

-CA$4m

Jan 31 2023n/an/a

-CA$3m

Oct 31 2022n/an/a

-CA$3m

Jul 31 2022n/an/a

-CA$3m

Apr 30 2022n/an/a

-CA$3m

Jan 31 2022n/an/a

-CA$4m

Oct 31 2021n/an/a

-CA$6m

Jul 31 2021n/an/a

-CA$6m

Apr 30 2021n/an/a

-CA$6m

Jan 31 2021n/an/a

-CA$5m

Oct 31 2020n/an/a

-CA$2m

Jul 31 2020n/an/a

-CA$162k

Apr 30 2020n/an/a

-CA$4m

Jan 31 2020n/an/a

-CA$8m

Oct 31 2019n/an/a

-CA$13m

Jul 31 2019CA$67kCA$60k

-CA$13m

Apr 30 2019n/an/a

-CA$12m

Jan 31 2019n/an/a

-CA$7m

Oct 31 2018n/an/a

-CA$12m

Jul 31 2018CA$67kn/a

-CA$12m

Apr 30 2018n/an/a

-CA$10m

Jan 31 2018n/an/a

-CA$11m

Oct 31 2017n/an/a

-CA$1m

Jul 31 2017CA$66kCA$60k

-CA$605k

Compensazione vs Mercato: Dati insufficienti per stabilire se la retribuzione totale di John sia ragionevole rispetto ad aziende di dimensioni simili nel mercato Canadian.

Compensazione vs guadagni: La retribuzione di John è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

John Miller

9.1yrs

Mandato

CA$66,750

Compensazione

Mr. John Miller serves as Chief Executive Officer at THC Biomed Intl Ltd. since April 29, 2015. He is also President at THC Biomed Intl Ltd.and its Director since June 3, 2014. He was Director and Office...


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
John Miller
President9.9yrsCA$66.75k19.14%
CA$ 627.5k
Jung Hee
Co-Founder9.9yrsCA$66.66k9.89%
CA$ 324.2k
Jason Springett
Member of Advisory Board8.8yrsNessun datoNessun dato
Donald Shaxon
Member of Advisory Board8.8yrsNessun datoNessun dato
Ashish Dave
Independent Director6.9yrsCA$6.50kNessun dato
Penelope Laine
Independent Director4.2yrsNessun dato0.0061%
CA$ 200.0

8.8yrs

Durata media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di THC sono considerati esperti (durata media dell'incarico 8.8 anni).